Physician profile
Mohammad Lababidi
NPI 1447712799
$1,674.31
in general payments reported to CMS, 2019-2025
16 companies · $632 in 2025
The $632 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $369 · 2024: $537 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $522.88 | 2022-2025 | Azstarys |
| Tris Pharma INC | $234.96 | 2022-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $168.79 | 2022-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $165.92 | 2023-2025 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $146.88 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $141.72 | 2023-2025 | Bexsero, Pediarix, Rotarix |
| Cranial Technologies, INC | $58.67 | 2024-2025 | Doc Band |
| Neurelis, INC. | $52.89 | 2022-2024 | Valtoco |
| Pfizer INC. | $42.56 | 2022-2025 | |
| Aytu Biopharma, INC. | $31.76 | 2024 | Karbinal |
| Sanofi Pasteur INC. | $23.88 | 2024 | |
| Ironwood Pharmaceuticals, INC | $22.41 | 2024 | |
| Cipher Pharmaceuticals US LLC | $20.32 | 2025 | Spinosad, Natroba |
| Sobi, INC | $13.82 | 2023 | |
| Vertical Pharmaceuticals, LLC | $13.71 | 2025 | Relexxii |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Lababidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.